Carolina Q Sacramento Selected Research

Carolina Q Sacramento Research Topics

Disease

15	COVID-19 01/2023 - 12/2020
9	Human Influenza (Influenza) 01/2023 - 01/2014
7	Infections 08/2022 - 01/2014
5	Inflammation (Inflammations) 01/2023 - 01/2021
3	Dengue (Dengue Fever) 01/2022 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2017
2	Cytokine Release Syndrome 01/2023 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2021
1	Lung Injury 01/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2022
1	Thromboinflammation 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Malaria 03/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Weight Loss (Weight Reduction) 01/2019
1	Yellow Fever 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Arthralgia (Joint Pain) 01/2019
1	Pain (Aches) 01/2019
1	Edema (Dropsy) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Neuroblastoma 01/2017

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2015
4	SofosbuvirIBA 01/2021 - 01/2017
3	CytokinesIBA 01/2022 - 01/2022
3	NucleotidesIBA 01/2022 - 01/2019
3	Neuraminidase (Sialidase)IBA 01/2020 - 01/2015
2	Exonucleases (3' 5' Exonuclease)IBA 01/2022 - 07/2021
2	LipidsIBA 01/2022 - 12/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	Viral RNAIBA 01/2022 - 07/2021
2	remdesivirIBA 01/2022 - 07/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2019 - 12/2018
2	VaccinesIBA 01/2019 - 01/2019
2	Hemagglutinins (Hemagglutinin)IBA 01/2015 - 01/2015
2	tetrahydrofuranIBA 01/2015 - 01/2015
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2015 - 01/2015
2	aureonitolIBA 01/2015 - 01/2015
1	Etanercept (Enbrel)FDA Link 01/2023
1	KinetinIBA 01/2023
1	Mefloquine (Lariam)FDA LinkGeneric 11/2022
1	Antimalarials (Antimalarial Agents)IBA 11/2022
1	4-aminoquinolineIBA 11/2022
1	Chloroquine (Aralen)FDA LinkGeneric 11/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	kaempferolIBA 01/2022
1	fisetinIBA 01/2022
1	myricetinIBA 01/2022
1	3-hydroxyflavoneIBA 01/2022
1	flavoneIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	FlavonoidsIBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	IsoflavonesIBA 01/2022
1	Membrane LipidsIBA 01/2022
1	NeuropeptidesIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	QuercetinIBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Vasodilator Agents (Vasodilators)IBA 01/2022
1	P-SelectinIBA 01/2022
1	Simvastatin (Zocor)FDA LinkGeneric 01/2022
1	GenisteinIBA 01/2022
1	Fibrinogen ReceptorsIBA 01/2022
1	ApigeninIBA 01/2022
1	LuteolinIBA 01/2022
1	Atazanavir Sulfate (Reyataz)FDA Link 12/2021
1	pyronaridineIBA 03/2021
1	Tilorone (Tilorone Hydrochloride)IBA 03/2021
1	Quinacrine (Mepacrine)IBA 03/2021
1	Sigma-1 ReceptorIBA 01/2021
1	daclatasvirIBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	CannabinoidsIBA 01/2021
1	4- (4- phenyl- 1H- 1,2,3- triazol- 1- yl)- 2,2,6,6- tetramethylpiperidine- 1- oxylIBA 01/2020
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	agathisflavoneIBA 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2019
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2019
1	RibonucleotidesIBA 12/2018
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 12/2018
1	triphosphoric acid (triphosphate)IBA 12/2018
1	QuinolonesIBA 12/2015
1	Oseltamivir (Tamiflu)FDA Link 12/2015
1	4-Quinolones (4 Quinolones)IBA 12/2015
1	Complement System Proteins (Complement)IBA 01/2014
1	RibonucleoproteinsIBA 01/2014

Therapy/Procedure

4	Therapeutics 01/2023 - 03/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Palliative Care (Palliative Therapy) 01/2019